Mission Wealth Management LP Sells 24 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Mission Wealth Management LP cut its position in Mettler-Toledo International Inc. (NYSE:MTD) by 2.5% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 927 shares of the medical instruments supplier’s stock after selling 24 shares during the period. Mission Wealth Management LP’s holdings in Mettler-Toledo International were worth $1,134,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. State Street Corp grew its stake in shares of Mettler-Toledo International by 1.0% in the third quarter. State Street Corp now owns 954,653 shares of the medical instruments supplier’s stock valued at $1,431,693,000 after buying an additional 9,009 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of Mettler-Toledo International by 0.8% in the third quarter. Geode Capital Management LLC now owns 547,439 shares of the medical instruments supplier’s stock valued at $818,906,000 after buying an additional 4,166 shares in the last quarter. Principal Financial Group Inc. grew its stake in shares of Mettler-Toledo International by 13.9% in the fourth quarter. Principal Financial Group Inc. now owns 274,563 shares of the medical instruments supplier’s stock valued at $335,977,000 after buying an additional 33,456 shares in the last quarter. Barclays PLC grew its stake in shares of Mettler-Toledo International by 8.3% in the third quarter. Barclays PLC now owns 256,602 shares of the medical instruments supplier’s stock valued at $384,822,000 after buying an additional 19,609 shares in the last quarter. Finally, JPMorgan Chase & Co. lifted its holdings in Mettler-Toledo International by 14.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock valued at $332,634,000 after purchasing an additional 28,478 shares during the last quarter. 95.07% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the company. Citigroup cut their price target on Mettler-Toledo International from $1,450.00 to $1,400.00 and set a “neutral” rating for the company in a report on Tuesday. Robert W. Baird raised their price target on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the company a “neutral” rating in a report on Monday, February 10th. Evercore ISI raised their price target on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an “outperform” rating in a report on Monday, February 10th. Stifel Nicolaus cut their price target on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a report on Monday, November 11th. Finally, Wells Fargo & Company raised their price target on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the company an “equal weight” rating in a report on Monday, February 10th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $1,380.50.

Insider Activity at Mettler-Toledo International

In related news, insider Gerry Keller sold 600 shares of the business’s stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total value of $810,804.00. Following the completion of the transaction, the insider now owns 6 shares of the company’s stock, valued at $8,108.04. The trade was a 99.01 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Christian Magloth sold 790 shares of the business’s stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the completion of the transaction, the insider now directly owns 734 shares of the company’s stock, valued at approximately $964,248.46. This trade represents a 51.84 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is owned by insiders.

Mettler-Toledo International Stock Performance

MTD opened at $1,242.44 on Wednesday. Mettler-Toledo International Inc. has a fifty-two week low of $1,142.91 and a fifty-two week high of $1,546.93. The company has a market capitalization of $25.99 billion, a P/E ratio of 30.65, a P/E/G ratio of 3.30 and a beta of 1.13. The stock has a fifty day moving average of $1,291.82 and a 200-day moving average of $1,326.68.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, topping analysts’ consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. On average, equities research analysts predict that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current fiscal year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.